How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

NT

NASDAQ:NTRA
Get a brief AI stock analysisSaves ~ 15 minutes of your time

NT

Natera IncNASDAQ NTRA Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is NTRA undervalued compared to its fair value?

The fair value of NTRA stock is hidden USD. Relative to the market price of 106.52 USD Natera Inc is hidden.

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. The company is headquartered in Austin, Texas and currently employs 2,958 full-time e...[More about valuation]

Natera Fair Value

Available for registered user
UNLOCK
What is fair value?

Market cap:

13.081 $B

Price:

106.52 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.56

FINANCIALS

Natera financial for reporting period

Income Statement

0.37 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.074 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.068 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.37 B 100%
0.21 B 57%
-0.074 B -20%
-0.068 B -18%

Balance Sheet

1.5 B
0.79 B


Financial Position Analysis

Assets

1.5 B
Current Assets
1.3 B
Total non-current assets
0.21 B

Total current liabilities
0.31 B
Total non-current liabilities
0.37 B

Cash Flow Statement

-0.0038 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.027 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Natera fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

-50 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-103 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-26 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Natera Rating

Is NTRA attractive for investment based on fundamental analysis?

NTRA stock rating is hidden. Natera is a hidden by Eyestock methodology.

Get NTRA Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-30

Gross Margin:

50

CFO / Debt ratio:

hidden

Current ratio:

4.112

Debt / Equity ratio:

0.494

ROE:

-50

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

NTRA analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for NTRA to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Natera Inc dividends

NTRA dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About NTRA stock

About the company Natera Inc

Market cap $B

13.081

Dividend yield

Shares outstanding

113.286 B

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. The company is headquartered in Austin, Texas and currently employs 2,958 full-time employees. The company went IPO on 2015-07-02. Its cell-free deoxyribonucleic acid (cfDNA) technology combines its molecular assays, which reliably measure many informative regions across the genome from samples as small as a single cell. The firm's product offerings include Panorama Non-Invasive Prenatal Test (NIPT), Vistara, Horizon Carrier Screening (HCS), Spectrum Preimplantation Genetics, Anora Miscarriage Test (Anora) and Prospera. The firm also offers Constellation, a cloud-based software platform that enables laboratory customers to gain access through the cloud to the Company’s algorithms and bioinformatics in order to validate and launch tests based on the Company’s technology. Its NIPT screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother.

NTRA profile

  • Ticker

    NTRA

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    02 July 2015

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    2958

  • City

    Austin

  • Address

    13011 Mccallen Pass, Building A Suite 100

  • Cusip

    632307104

Frequently Asked Questions

What sector does Natera operate in?

Natera operates in Healthсare sector

What is market cap of Natera?

Market cap of Natera is 13.081 USD as of 24 Jul 2024

What is market price of one NTRA stock?

Market price of one NTRA stock is 106.52 USD as of 24 Jul 2024

What is Natera revenue?

According to the recent report Natera revenue is 367.741

What is Natera net income?

According to the recent report Natera net icnome is -67.599

What is Natera net income growh rate?

Net income growth rate of Natera is 54